Other genes represent a genetic variation which correlates with increased pancreatic cancer risk (ERCC4) [40], have been related to pancreatic cancer development (CCDC18 or DGKD) [41, 42], can predict the prognosis or risk for other cancers (PDPN and TMC6) [43, 44], or have been related to cell proliferation and migration (EYA2) [45]. This evidence concerns the gene ERCC4 and pancreatic neoplasm.